Skip to the main content.

Cell and Gene Therapy Series. Part 2

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 2

PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?

Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.

This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
The Future of Aseptic Manufacturing: Compact and Advanced Solutions

The Future of Aseptic Manufacturing: Compact and Advanced Solutions

David Johnson: 24 November 2025

As the pharmaceutical industry advances into more complex modalities, from biologics to cell and gene therapies, the need for flexible,...

Read More
Putting Annex 1 into Practice: What Small-Batch Manufacturers Need to Know

Putting Annex 1 into Practice: What Small-Batch Manufacturers Need to Know

David Johnson: 24 November 2025

In this webinar recap, David Johnson, Sales & Marketing Director at 3P innovation, and Tracy Moore, Principal Consultant at TM Pharma and former...

Read More
Precision Blister Filling: Ensuring Consistent Dose Delivery in DPIs

Precision Blister Filling: Ensuring Consistent Dose Delivery in DPIs

Tom Bailey: 21 November 2025

Read More